E2020
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
358 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 34 | 48 | 30 | 37 | 42 | 187 |
| Dementia | D003704 | EFO_0003862 | F03 | 4 | 8 | 15 | 11 | 15 | 53 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | 9 | 13 | 7 | 8 | 8 | 44 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | 5 | 3 | 5 | 3 | 17 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 2 | 2 | 3 | 3 | 2 | 11 |
| Cognition disorders | D003072 | — | — | 1 | 4 | — | 3 | 2 | 9 |
| Lewy body disease | D020961 | EFO_0006792 | G31.83 | — | 2 | 1 | 2 | 4 | 9 |
| Memory disorders | D008569 | — | — | 2 | 1 | 2 | 1 | 2 | 8 |
| Depression | D003863 | — | F33.9 | — | 2 | 2 | 2 | — | 6 |
| Vascular dementia | D015140 | — | F01 | 1 | — | 3 | 1 | 1 | 6 |
Show 39 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Syndrome | D013577 | — | — | 1 | 4 | 4 | — | 1 | 10 |
| Down syndrome | D004314 | EFO_0001064 | Q90 | — | 3 | 2 | — | — | 5 |
| Mixed dementias | D000093902 | — | — | — | — | 1 | — | 2 | 3 |
| Radiation effects | D011830 | — | — | 1 | 1 | 1 | — | — | 3 |
| Rett syndrome | D015518 | Orphanet_778 | F84.2 | — | — | 1 | — | 1 | 2 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 1 | 1 | — | — | 2 |
| Brain injuries | D001930 | — | S06.9 | 1 | 1 | 1 | — | — | 2 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | 2 | 1 | — | — | 2 |
| Alcohol drinking | D000428 | EFO_0004329 | — | — | 2 | 1 | — | — | 2 |
| Ischemic stroke | D000083242 | — | — | — | 1 | 1 | — | — | 2 |
Show 12 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cocaine-related disorders | D019970 | — | F14 | — | 3 | — | — | — | 3 |
| Central nervous system neoplasms | D016543 | — | — | 2 | 1 | — | — | — | 3 |
| Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | — | 2 | — | — | — | 2 |
| Fragile x syndrome | D005600 | — | Q99.2 | 1 | 1 | — | — | — | 2 |
| Nervous system neoplasms | D009423 | — | — | 1 | 1 | — | — | — | 2 |
| Anorexia | D000855 | HP_0002039 | R63.0 | — | 2 | — | — | — | 2 |
| Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | — | 2 | — | — | — | 2 |
| Consciousness disorders | D003244 | — | — | 1 | 1 | — | — | — | 1 |
| Pervasive child development disorders | D002659 | EFO_0003756 | F84 | — | 1 | — | — | — | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Show 20 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 31 | — | — | — | 1 | 32 |
| Nervous system diseases | D009422 | — | G00-G99 | 2 | — | — | — | 2 | 4 |
| Central nervous system diseases | D002493 | HP_0002011 | G96.9 | 2 | — | — | — | 1 | 3 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 3 | — | — | — | — | 3 |
| Crush injuries | D000071576 | — | T14.8 | 1 | — | — | — | — | 1 |
| Rh isoimmunization | D012203 | EFO_1001159 | — | 1 | — | — | — | — | 1 |
| Neurotoxicity syndromes | D020258 | — | G92 | 1 | — | — | — | — | 1 |
| Visual perception | D014796 | GO_0007601 | — | 1 | — | — | — | — | 1 |
| Attention | D001288 | — | — | 1 | — | — | — | — | 1 |
| Non-neuronal cholinergic system | D000070634 | — | — | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy aging | D000073656 | — | — | — | — | — | — | 2 | 2 |
| Brain diseases | D001927 | HP_0001298 | G93.40 | — | — | — | — | 2 | 2 |
| Neurodegenerative diseases | D019636 | EFO_0005772 | G31.9 | — | — | — | — | 2 | 2 |
| Late onset disorders | D000067562 | — | — | — | — | — | — | 1 | 1 |
| Tauopathies | D024801 | — | — | — | — | — | — | 1 | 1 |
| Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | — | — | 1 | 1 |
| Gait | D005684 | — | — | — | — | — | — | 1 | 1 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | — | 1 | 1 |
| Gastrointestinal motility | D005769 | — | — | — | — | — | — | 1 | 1 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 1 | 1 |
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use